Stichting OLVG — Clinical Trial Site

81 Registered trials

37 Currently recruiting

Organisation

Stichting OLVG

Location

Amsterdam, Netherlands

Identifier

ORG-100029947

Address

Oosterpark 9, 1091 AC, Netherlands

Departments

#1703: Cardiology
#2901:Cardiology
#3724: Cardiology
2619:Cardiology
3724: Cardiology
Anaesthesia
Anesthesiology
Cardiology
Cardiology Research
Department of Gastroenterology & hepatology
Department of Surgery
Gastroenterology
Gynecology and obstetrics
Hematologie Oncologie
Hematology
Hematology-Oncology
Intensive Care
Internal Disease
Internal Medicine
Internal medicine / Oncology
Interne geneeskunde
MDL
Medical Oncology
Medical Oncology and Hematology
N/A
NA
Neurologie
Neurology
Obstrics & Gynecology
Oncology
Ophthalmology
Orthopedic surgery
orthopedics
Psychiatry
Pulmonology
Secretariaat cardiologie research N3.59
Surgery
Surgery HPB and colorectal

Clinical trials at this site (81)

Search interface

SAFEST Not authorised

2022-502059-79-00 Ischemic stroke or transient ischemic attack 6
A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Unknown

2022-502779-40-99 Primary prevention of atherosclerotic cardiovascular di 5
A clinical study of MK-7240 for the treatment of ulcerative colitis (MK-7240-001) Unknown

2025-523766-25-00 Ulcerative colitis 5
RATE: Reduced anticoagulation targets in extracorporeal life support Pending

2023-509675-16-01 All patients who receive ECMO treatment during the stud 5
Adjuvant hepatic arterial infusion pump chemotherapy after resection of colorectal liver metastases in patients with a low clinical risk sco… Pending

2024-512850-10-00 Resectable colorectal rectal metastases without extrahe 5
Ultrasound-guided Radiofrequency Ablation versus radioactive Iodine as treatment for Hyperthyroidism caused by Solitary Autonomous Thyroid N… Pending

2024-515602-34-01 Hyperactive thyroid nodules 11
ATLAS trial Pending

2024-517233-40-00 Perianal abscess 6
Adjuvant Pembrolizumab in patients with early-stage triple negative breast cancer with residual disease after treatment with chemotherapy an… Pending

2025-524229-41-00 Triple negative breast cancer 5
An open-label extension (OLE) trial to evaluate long-term safety and tolerability of pelacarsen (TQJ230) Recruiting

2024-519870-38-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2026-05-11
A study to investigate the effect of adding bleximenib to standard-of-care treatment with intensive chemotherapy in patients with a specific… Recruiting

2025-522767-15-00 Acute Myeloid Leukemia 5 2026-01-27
A study investigating the effect of adding revumenib to treatment with venetoclax + azacitidine in patients with acute myeloid leukemia (AML… Recruiting

2024-512733-32-00 Acute Myeloid Leukemia (AML) 5 2025-03-31
A multi-centred, partially randomised, patient-preference trial of radical surgery versus adjuvant chemoradiotherapy after local excision fo… Recruiting

2024-517410-15-01 Rectal cancer 5 2025-01-14
Perioperative versus adjuvant FOLFIRINOX for resectable pancreatic cancer: the PREOPANC-3 study Recruiting

2024-510617-15-00 Non-metastatic resectable pancreatic cancer 5 2024-09-06
This study is to find out the safety and effectiveness of Epcoritamab together with R-CHOP (rituximab, cyclophosphamide, doxorubicin HCL, vi… Recruiting

2023-505277-32-00 Diffuse Large B-Cell Lymphoma (DLBCL) 5 2023-01-26
PUMP-IT RCT: Hepatic arterial infusion PUMP chemotherapy combined with systemic therapy versus systemic therapy alone as Induction Therapy f… Recruiting

2023-506194-35-00 Colorectal liver metastases 5 2026-05-22
OCEAN(a)-CCTA - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction -Coronary Computed Tomography Angiography trial Recruiting

2025-521117-88-00 Cardiovascular Disease 5 2026-03-11
Sleeping through Menopause Recruiting

2024-512071-12-00 Insomnia 6 2025-10-29
EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure… Recruiting

2025-521188-11-00 Type 2 diabetes 5 2025-10-15
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and … Recruiting

2024-516652-18-00 Atherosclerotic cardiovascular disease (ASCVD) and obes 5 2025-10-10
Preventing postoperative complications in patients undergoing high-risk pancreatoduodenectomy with a bundle approach including hydrocortison… Recruiting

2024-519667-18-00 Pancreatic conditions requiring pancreaticoduodenectomy 6 2025-08-21
Continuing ovulation induction with letrozole versus switching to gonadotropins in women with polycystic ovary syndrome (MOVIN-II study) Recruiting

2024-519354-36-00 Polycystic ovary syndrome (PCOS) 6 2025-08-01
StAtins in Frail oldEr patients with ischemic Stroke or Transient ischemic attack – The Randomized Controlled Trial Recruiting

2024-517343-31-00 Ischemic stroke and transient ischemic attack 6 2025-04-11
BuLLSEYE Recruiting

2024-512950-13-00 Sepsis 11 2025-01-03
Stopping or continuing blood thinners after stroke at young age without a known cause: STOP trial Recruiting

2024-513092-40-00 Stroke 6 2024-12-05